Skip to content
MedsAcross

Medicine

Ampicillin and Sulbactam 1 g/0.5 g per 1.5 g powder for injection

Available on requestPrescription onlyUS FDAGeneric name

Ampicillin and Sulbactam 1 g/0.5 g per 1.5 g powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

The following packages are available: Single-dose vials containing 1.5 g (NDC…

Key facts

Active ingredient (INN)
Ampicillin and Sulbactam
Brand
Sold under the generic name
Strength
1 g/0.5 g per 1.5 g
Dosage form
Powder for injection
Route
Intravenous
Packs
10 vials
Manufacturer
Hikma Pharmaceuticals
Origin register
US FDA, United States
Storage
The following packages are available: Single-dose vials containing 1.5 g (NDC 0641-6116-10) equivalent of Ampicillin and Sulbactam for Injection, USP (1 g ampicillin as the sodium salt plus 0.5 g sulbactam as the sodium salt) Single-dose vials containing 3 g (NDC 0641-6117-10) equivalent of Ampicillin and Sulbactam for Injection, USP (2 g ampicillin as the sodium salt plus 1 g sulbactam as the…
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
22 December 2009
Identifiers
RxCUI 1659592, 1659598DailyMed set ID d3026cc0-95d8-44cf-be47-b5ebb8fd4568NDC 0641-6116, 0641-6117Application ANDA065406

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 vial in 1 carton / 1.5 g in 1 vial0641-6116-10Hikma Pharmaceuticals22 December 2009
10 vial in 1 carton / 3 g in 1 vial0641-6117-10Hikma Pharmaceuticals22 December 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Ampicillin and Sulbactam

Clinical summary

Ampicillin and Sulbactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. MedsAcross supplies Ampicillin and Sulbactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ampicillin and Sulbactam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ampicillin and Sulbactam 1 g/0.5 g per 1.5 g powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.